Chicago - Although some drugs used to treat psoriasis are known teratogens, dermatologists still have a range of options they might choose from for managing psoriasis across its spectrum of severity in women who are or wish to become pregnant, Mark Lebwohl, M.D., said at Academy '03.
Auckland, New Zealand - Intradermal injection of a purified cell wall component from heat-killed Mycobacterium vaccae may one day be used to treat children with severe atopic dermatitis, if a clinical program carried out by a New Zealand company continues to be successful.
Being a drummer is nothing like being a dermatologist, but Arthur W. Richardson, M.D., does both with passion. Friends of the semi-retired San Antonio dermatologist would call him "the skin man" for his drum playing ability - that was before Dr. Richardson became a "skin doctor."
New York - With the results of two previous open trials supporting clinical use of tacrolimus (Protopic) and pimecrolimus (Elidel), current data affirms that the topical immunomodulators are the definitive treatment of choice for facial and intertriginous psoriasis, according to Mark Lebwohl, M.D.
Chicago - Innovative therapeutic approaches may be needed to manage patients with localized psoriasis who despite having only limited areas of disease can present a major therapeutic challenge for dermatologists, said Steven R. Feldman, M.D., Ph.D.
The FDA will review both Medicis Pharmaceutical Corp.'s Restylane and Inamed Corp's Hylaform on November 21.
Permanent cosmetics, which are essentially tattoos, are causing some concern because of mistakes that are difficult to fix.
Astralis has begun Phase I clinical trial for Psoraxine for the treatment of moderate plaque psoriasis.
A new drug, Onercept or r-hTBP-1, seems promising in the treatment of psoriasis.
An advisory board to the Food and Drug Administration was unanimous in recommending the approval of Raptiva, a psoriasis drug manufactured by Genentech.
The FDA has approved Cubicin, a product of Cubist Pharmaceuticals that was formally called Cidecin, for treatment of complicated skin and structure infections caused by gram-positive bacteria.
Atopic eczema is best treated before it actually flares up, according to research presented at the World Allergy Congress.
A preliminary study shows that a peptide developed by Helix BioMedix Inc. can help reduce the severity of mild to moderate acne.
According to a report by Reuters Health, owners of tropical fish need to take special precautions when cleaning the tank.
The FDA has approved a supplemental new drug application for Valtrex (valacyclovir HCI) manufactured by GlaxoSmithKline.
When a Division of Dermatology in Wright State's College of Medicine placed a newspaper ad to recruit volunteers for a tattoo-removal study, more than 100 people responded.
In Texas, voters approved a constitutional amendment limiting medical malpractice awards.
Galderma Laboratories has formed a new sales division, Theracutix, which will supplement the company's two current sales divisions: Galderma and CutiScience.
Ecolab Inc. sold the consumer dermatology business of its Adams Healthcare subsidiary to Britain's Ferndale Pharmaceuticals Ltd.
The U.S. Army offers a website to help aspiring healthcare professionals.
Cytochroma Inc. discovered a new gene ? CYP26C ? which encodes a retinoic-acid-metabolizing enzyme.
MacroChem Corporation has formed a scientific advisory board to help the company in evaluating new applications for its current transdermal technologies.
Helix BioMedix completed a preliminary study designed to evaluate the efficacy of one the company's proprietary peptides, HB64, in reducing severity of mild to moderate acne symptoms.
Enfis, a Wales-based company, is working to bring to market a laser designed to cure acne and has been given the go-ahead to start clinical trials.
Biologics manufacturers cite complex research and development process,along with FDA scrutiny, as reason for costly - but worthy - drugs
